| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |